The document discusses Herpes Zoster (shingles), caused by the varicella zoster virus which causes chickenpox. After initial chickenpox infection, the virus can lay dormant in nerve fibers and reactivate as shingles, presenting as a painful rash localized to specific dermatomes. The rash involves clusters of vesicles in a band-like distribution along dermatomes. Treatment involves antiviral drugs to reduce symptoms and analgesics to manage pain. Nursing care focuses on preventing secondary infection, managing pain and promoting comfort during the infection period.
viral infection of the nerve cells and surrounding skin, caused by the varicella zoster virus
what we basically see in ths conditions
what basic things to remember always....
viral infection of the nerve cells and surrounding skin, caused by the varicella zoster virus
what we basically see in ths conditions
what basic things to remember always....
dermatological disease caused by bacterial infection (Staphylococcus aureus & Streptococcus pyrogen) contagious disease but it is easy to cure by taking oral antibiotics and topical antibiotic cream
dermatological disease caused by bacterial infection (Staphylococcus aureus & Streptococcus pyrogen) contagious disease but it is easy to cure by taking oral antibiotics and topical antibiotic cream
Herpes zoster is a localised disease caused by reactivation of the varicella zoster virus that enters the cutaneous nerve endings during an earlier episode of chicken pox, travels to the dorsal root ganglia, and remains in latent form. The condition is characterised by occurrence of multiple, painful, unilateral vesicles and ulceration, and shows a typical single dermatome innervated by single dorsal root or cranial sensory ganglion.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. Definition
Commonly known as “ Shingles”
After initial exposure, Herpes Zoster lies foemant
in certain nerve fibers.
It may become active as a result of many factors
such as aging, stress, suppression of the immune
system, and certain medications.
3. Etiologic Agent
Varicella- zoster (V-Z) virus
Same virus responsible for chickenpox (varicella)
The virus occurs in partially immune individuals
due to previous varicella infection.
5. Period of Communicability
Herpes zoster is communicable a day before the
appearance of the first rash until five to six days
after the last crust disappears.
6. Mode of Transmission
Herpes zoster can be transmitted through direct
contact, specifically, through droplet infection
and airborne spread.
It can also be transmitted through indirect
contact, e.g., articles freshly soiled by secretions
and discharges from an infected person.
7. Pathogenesis
The varicella zoster virus may persist in a
dormant state in the dorsal nerve root ganglia.
The virus may later emerge from the site, either
spontaneously or in association with
immunosuppression, to cause herpes zoster.
It produces localized vesicular skin lesions
confined to a dermatome and severe neurologic
pain in the peripheral areas innervated by the
nerves arising in the inflamed root ganglia.
This infection usually occurs in adults.
9. Clinical Manifestations
Any part of the trunk may be affected, but the
thoracic segment is commonly involved. Other
areas that may be affected are the extremities
and branches of the 5th and 7th cranial nerves.
The virus affects the ganglion of the posterior
nerve roots or the extramedullary cranial nerve
ganglion.
10. Clinical Manifestations
1. The erythematous base of the skin lesion
appears first. It is followed by the appearance of
the vesicles within 24 hours. A cluster of
vesicles appears to form patches, which
coalesce to form an irregular, band-like
distribution along the course of involved
dermatomes. Eruptions are unilateral and never
cross the midline of the body. The vesicles
become pustular, breakdown, and form crusts.
Lesions may last for one to two weeks.
11. Clinical Manifestations
2. Pain of varying intensity is a presenting
symptom in about two-thirds of patients. Pain
occurs from one to five days prior to the
development of rash and is neuralgic and
paroxysmal in type. The pain may be described
as burning or stabbing. Patient may complain of
pruritus. The pain is usually worse at night and
is intensified by movement.
12. Clinical Manifestations
3. Fever, malaise, anorexia, and headache occur
for one or more days.
4. Regional lymph nodes are involved in the early
stage of the disease.
5. When the ophthalmic (5th cranial) nerve is
affected, corneal anesthesia may occur, and the
condition is known as Gasserian ganglionitis.
6. Paralysis of the facial nerve and vesicles in the
external auditory canal affects the 7th cranial
nerve. The condition is called Ramsay- Hunt
Syndrome.
13. Diagnostic Exam
1. The characteristic skin rash may be
diagnostic.
2. Tissue culture technique- the virus may
be isolated from fluid taken from newly
developing vesicles.
3. Smear of vesicle fluid
4. Microscopy
15. Modalities of Treatment
1. Symptomatic
2. Antiviral drugs
3. Analgesics to control pain
4. Anti-inflammatory
16. Nursing Management
1. Keep the patient comfortable. Maintain meticulous
hygiene.
2. Keep the patient in strict isolation.
3. Apply cool, wet dressings with NSS to pruritic
lesions.
4. Efforts should be made to prevent secondary
infection.
5. Prevent entrance of microorganism into the lesions,
especially if they are broken.
6. Assess the degree of pain. To avoid neuralgic pain,
do not delay the administration of pain relievers are
prescribed.
7. Encourage sufficient bed rest and provide
supportive care to promote proper healing lesions.
8. Provide the patient with a diversionary activity to
take his mind off the pain and the pruritus.
17. Common Nursing Diagnoses
1. Pain
2. Alteration of comfort
3. Body image disturbance
4. Risk of infection
5. Impaired physical mobility
6. Impaired skin integrity
7. Altered role performance
18. Comparison Between Shingles
and Varicella
Clinical Feature Chickenpox Herpes Zoster
Causative Agent Varicella Virus VZ Virus
Period of
communicability
A day before the
eruption of the 1st
rash up to 5 days
after last crust
Same as in
chickenpox
Evolution of rashes Macule papule
vesicle
pustule
Same as in chicken
pox
Distribution of rashes • Appears first on
the unexposed
part of the body
• Generalized
• Clustered
• Unilateral
• Does not cross the
sagittal portion of
the body
19. Comparison Between Shingles
and Varicella
Clinical Feature Chickenpox Herpes Zoster
Manifestation Itchy • Deep-seated burning
pain that is usually
worst at night
• Lymphadenopathy
• Corneal anesthesia
(Gasserian
Ganglionitis)
• Paralysis of the facial
nerve and the external
auditory canal (
Ramsay- Hunt
Syndrome)
Drug/s of choice • Acyclovir (Zovirax)
• Antipyretic for fever
• Calamine lotion
• Acyclovir
• Analgesics to control
pain
• Anti-inflammatory
Nursing Management • Management is geared
towards the relief of
itchiness
Same as in chickenpox
20. Prevention
Immunization against chickenpox
Avoid exposure to a patient suffering from either
varicella or herpes zoster
Increase the patient’s immune resistance
21. Reference:
D. Navales. (2010). 3rd edition. Handbook of
common communicable and infectious diseases.
Herpes Zoster. Pg.115